Kennedy’s ACIP Backs Monoclonal Antibody for RSV Prevention in Infants

(MedPage Today) — The CDC’s newly reconstituted Advisory Committee on Immunization Practices (ACIP) voted 5-2 in support of infants younger than 8 months receiving clesrovimab (Enflonsia) to prevent respiratory syncytial virus (RSV).
While lawmakers…